5982 related articles for article (PubMed ID: 3834791)
1. Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
Samson MK; Haas CD; Baker LH; Cummings G
Am J Clin Oncol; 1985 Apr; 8(2):167-71. PubMed ID: 3834791
[TBL] [Abstract][Full Text] [Related]
2. Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Long HJ; Green SJ
Med Pediatr Oncol; 1986; 14(2):86-7. PubMed ID: 3713642
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.
Amato DA; Bruckner H; Guerry D; Ash A; Falkson G; Borden EC; Creech RH; Savlov ED; Cunningham TJ
Invest New Drugs; 1987; 5(3):293-7. PubMed ID: 3667165
[TBL] [Abstract][Full Text] [Related]
4. High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
Murren JR; DeRosa W; Durivage HJ; Davis C; Makuch R; Portlock CS
Cancer; 1991 Mar; 67(6):1514-7. PubMed ID: 2001539
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma.
Mulder NH; Sleijfer DT; Smit JM; De Vries EG; Willemse PH; Koops HS
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):879-81. PubMed ID: 2429842
[TBL] [Abstract][Full Text] [Related]
6. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.
Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
Cancer Treat Rep; 1978 Dec; 62(12):2095-9. PubMed ID: 751717
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of dibromodulcitol and BCNU in metastatic malignant melanoma.
Clamon G; Sinkey C; Jochimsen P
Am J Clin Oncol; 1985 Jun; 8(3):244-6. PubMed ID: 4050743
[TBL] [Abstract][Full Text] [Related]
8. Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
Robidoux A; Gutterman JU; Bodey GP; Hersh EM
Cancer; 1982 Jun; 49(11):2246-51. PubMed ID: 7042068
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
[TBL] [Abstract][Full Text] [Related]
10. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
11. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W
Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.
Polyzos A; Legha SS; Burgess AM; Benjamin RS; Bodey GP
Invest New Drugs; 1988 Apr; 6(1):57-61. PubMed ID: 3410667
[TBL] [Abstract][Full Text] [Related]
13. Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.
Samson MK; Baker LH; Talley RW; Fraile RJ; McDonald B
Cancer Treat Rep; 1978 Aug; 62(8):1223-5. PubMed ID: 356980
[TBL] [Abstract][Full Text] [Related]
14. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Steffens TA; Bajorin DF; Chapman PB; Lovett DR; Cody-Johnson BV; Templeton MA; Heelan RT; Wong GY; Portlock CS; Oettgen HF
Cancer; 1991 Sep; 68(6):1230-7. PubMed ID: 1873774
[TBL] [Abstract][Full Text] [Related]
16. Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanoma.
Thatcher N; Wagstaff J; Mene A; Smith D; Orton C; Craig P
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):1009-14. PubMed ID: 3770045
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group Study.
Fletcher WS; Green S; Fletcher JR; Dana B; Jewell W; Townsend RA
Am J Clin Oncol; 1988 Oct; 11(5):589-93. PubMed ID: 3177261
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma.
Feun LG; Savaraj N; Hurley J; Marini A
Cancer Invest; 2002; 20(3):357-61. PubMed ID: 12025231
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of dibromodulcitol (DBD) in stage IV melanoma.
Hopkins J; Richards F; Case D; Pope E; Jackson DV; Stuart JJ; Muss HB; White DR; Cooper MR; Spurr CL
Am J Clin Oncol; 1984 Oct; 7(5):555-6. PubMed ID: 6507378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
